Back to search

Article

Neurodoron® in patients with neurasthenia – A randomized, double-blind, placebo-controlled clinical trial

2022-09-04

Abstract excerpt

1 <h4>Introduction</h4> The term neurasthenia has been introduced in the late 19th century. Stress was indicated as one of the main triggers. Many treatment options are available to reduce the associated symptoms. Complementary and alternative medicine (CAM) is widely used due to its long tradition and positive safety profile. This Phase IV placebo-controlled clinical trial was designed to demonstrate efficacy and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
13d7a330-9107-5269-8e7e-fd432ed3f533
DOI
10.1101/2022.09.02.22279531
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neurodoron® in patients with neurasthenia – A randomized, double-blind, placebo-controlled clinical trialDOI 10.1101/2022.09.02.22279531
Select a neighboring publication to make it the new centre.